Detalhe da pesquisa
1.
Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
Blood
; 143(10): 933-937, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194681
2.
SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol
; 43(8): e1258-e1259, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902067
3.
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL.
J Clin Oncol
; 42(8): 907-914, 2024 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967307